Rx ACCESS Act
The Rx ACCESS Act amends the TRICARE pharmacy benefits program to expand beneficiary choice in how they receive non-generic prescription medications starting October 1, 2026. The bill establishes mini…
Every bill below is the public record. Take the 2-minute values quiz and DeepSyte scores each one — and every vote your reps cast on them — against the issues you care about.
Federal legislation · 119th Congress
The Rx ACCESS Act amends the TRICARE pharmacy benefits program to expand beneficiary choice in how they receive non-generic prescription medications starting October 1, 2026. The bill establishes mini…
The bill directs the Secretary of Veterans Affairs to establish a five-year pilot program that awards competitive grants to nonprofit entities to provide service dogs to eligible veterans, with grants…
This bill establishes leave policies for members of the Armed Forces and their dependents to access non-covered reproductive health care, including abortion care and assisted reproductive technology (…
This bill requires U.S. Immigration and Customs Enforcement (ICE) and U.S. Customs and Border Protection (CBP) to establish standardized protocols for health screenings and medical care of detainees i…
This bill requires the Department of Veterans Affairs to implement a five-year pilot program to furnish, under the Veterans Community Care Program, hyperbaric oxygen therapy to veterans with traumatic…
This bill reauthorizes the Over-the-Counter (OTC) Monograph Drug User Fee Program (OMUFA) through FY2030 and revises certain aspects of the program, including total fees to be collected and fee due da…
This bill amends the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter (OTC) monograph drugs through fiscal year 2030. It modifies fee assessment peri…
The Access to Birth Control Act amends the Public Health Service Act to establish duties for pharmacies that stock contraceptives to ensure provision of FDA-approved contraception and related medicati…
This bill prohibits parties from entering into any agreement that resolves or settles a patent claim related to the sale of a drug or biological product and that has anticompetitive effects. Such an a…
This bill prohibits product hopping by drug manufacturers and authorizes the Federal Trade Commission (FTC) to enforce this prohibition. Generally, product hopping describes a situation where, when t…